CNN examines HIV clinic in Myanmar

CNN examines an HIV clinic in Myanmar, where the disease "is little understood" and "many of the patients here have nowhere else to go after being ostracized by their families." The clinic -- "started by pro-democracy leader Aung San Syi Kyi's party, the National League for Democracy," and run "on donations from private enterprises, individuals and AZG, the Dutch arm of Doctors Without Borders" -- is one of two in the country, which has one of the lowest per capita spending rates on health, just $23, in the world, according to the WHO, CNN reports. "Only recently have authorities in Myanmar admitted to an HIV/AIDS problem in the country," and "officials from the newly installed civilian government [have] agreed on a five-year plan to reduce stigma and spread of the disease," the news service writes (Hancocks, 12/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug